Literature DB >> 3155759

Intracoronary thrombus: role in coronary occlusion complicating percutaneous transluminal coronary angioplasty.

T A Mabin, D R Holmes, H C Smith, R E Vlietstra, A A Bove, G S Reeder, J H Chesebro, J F Bresnahan, T A Orszulak.   

Abstract

Angiograms from 238 consecutive patients who underwent percutaneous transluminal coronary angioplasty at the Mayo Clinic were reviewed to determine the presence of intracoronary thrombus before dilation. Patients with previously occluded vessels and those receiving streptokinase therapy were excluded. Intracoronary thrombus before dilation was present in 15 patients (6%); complete occlusion occurred in 11 (73%) of these during or immediately after dilation. None of these patients had angiographic evidence of major intimal dissection. In contrast, among the 223 patients in whom no intracoronary thrombus was present before dilation, complete occlusion occurred in 18 (8%) and in 12 was associated with major intimal dissection. The difference between the complete occlusion rates for patients with and without prior intracoronary thrombus was highly significant (73 versus 8%, respectively, p less than 0.001). Therefore, the presence of intracoronary thrombus identifies a group of patients who are at increased risk of developing complete occlusion during or after attempted coronary artery dilation.

Entities:  

Mesh:

Year:  1985        PMID: 3155759     DOI: 10.1016/s0735-1097(85)80037-1

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  22 in total

Review 1.  Antiplatelet therapy in interventional cardiology: II. Glycoprotein IIb/IIIa inhibitors.

Authors:  F H Jafary; C D Kimmelstiel
Journal:  J Thromb Thrombolysis       Date:  2000-02       Impact factor: 2.300

2.  Segmentally enclosed thrombolysis in percutaneous transluminal angioplasty for femoropopliteal occlusions: a report from a pilot study.

Authors:  B Jørgensen; K H Tønnesen; J D Nielsen; P Holstein; J Bülow; M Jørgensen; E Andersen
Journal:  Cardiovasc Intervent Radiol       Date:  1991 Sep-Oct       Impact factor: 2.740

Review 3.  Thrombosis in ST-elevation myocardial infarction: Insights from thrombi retrieved by aspiration thrombectomy.

Authors:  Daniel Rios P Ribeiro; Eduardo Cambruzzi; Marcia Moura Schmidt; Alexandre S Quadros
Journal:  World J Cardiol       Date:  2016-06-26

4.  Presence of multiple coronary angiographic characteristics for the diagnosis of acute coronary thrombus.

Authors:  Alok R Amraotkar; Shahab Ghafghazi; Patrick J Trainor; Charles W Hargis; Affan B Irfan; Shesh N Rai; Aruni Bhatnagar; Andrew P DeFilippis
Journal:  Cardiol J       Date:  2017-02-02       Impact factor: 2.737

5.  Inter- and intra-observer variability in the qualitative categorization of coronary angiograms.

Authors:  J P Herrman; A Azar; V A Umans; E Boersma; G A von Es; P W Serruys
Journal:  Int J Card Imaging       Date:  1996-03

Review 6.  Treatment of thrombus containing lesions in diseased native coronary arteries and saphenous vein bypass grafts using the AngioJet Rapid Thrombectomy System.

Authors:  J N Hamburger; P W Serruys
Journal:  Herz       Date:  1997-12       Impact factor: 1.443

Review 7.  Heparin dose during percutaneous coronary intervention: how low dare we go?

Authors:  G Niccoli; A P Banning
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

Review 8.  A new look at coronary angiograms: plaque morphology as a help to diagnosis and to evaluate outcome.

Authors:  J Lespérance; P Théroux; G Hudon; D Waters
Journal:  Int J Card Imaging       Date:  1994-06

Review 9.  Revascularization therapy for coronary artery disease. Coronary artery bypass grafting versus percutaneous transluminal coronary angioplasty.

Authors:  J M Wilson; J J Ferguson
Journal:  Tex Heart Inst J       Date:  1995

10.  Intracoronary versus intravenous abciximab in ST-segment elevation myocardial infarction: rationale and design of the CICERO trial in patients undergoing primary percutaneous coronary intervention with thrombus aspiration.

Authors:  Youlan L Gu; Marieke L Fokkema; Marthe A Kampinga; Bart J G L de Smet; Eng S Tan; Ad F M van den Heuvel; Felix Zijlstra
Journal:  Trials       Date:  2009-09-28       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.